Skip to main navigation
logo
Investors
  • News Archive
  • Past Events and Presentations
  • Stock History

News Archive

News Archive

Dec 18, 2019
Pfizer and Mylan Announce Two Future Viatris Board Members
Dec 02, 2019
Mylan and Biocon Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.
Nov 25, 2019
Mylan to Present at the Evercore ISI HealthCONx Conference
Nov 20, 2019
Mylan Announcement of Redemption of Certain Notes Due 2020
Nov 12, 2019
Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
Nov 05, 2019
Mylan Reports Third Quarter 2019 Results and Updates 2019 Guidance
Oct 25, 2019
Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance
Oct 24, 2019
Mylan to Release Third Quarter 2019 Financial Results on Nov. 5, 2019
Oct 21, 2019
Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting
Sep 27, 2019
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page next ›
  • Last page last »
Share

Utility Nav

  • Privacy Statement
  • Terms and Conditions
©2023 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.
mylan